US Pharmacopeia

US Pharmacopeia

Pharmaceutical Manufacturing

Rockville, Maryland 159,971 followers

The Standard of Trust.

About us

US Pharmacopeia (USP) is an independent, scientific nonprofit organization that has focused on building trust in the supply of safe, quality medicines since 1820. We are a public health organization that uses rigorous science and public quality standards setting to protect patient safety and improve global health. We are committed to building public trust and confidence in drug therapies to enable people to live longer and healthier, and also work to building trust in dietary supplements and food ingredients. Currently, we are working to strengthen the global supply chain so that the medicines people rely on are available when needed and work as expected. Our Volunteers USP standards are in a continuous process of review and revision based upon new evidence, emerging public health concerns, and public requests for revision. Input from our volunteers, through our Council of Experts and Expert Committees and Panels, is crucial for maintaining our standards and preserving public trust. Our Governing Bodies The USP Convention helps guide our areas of impact – nearly 500 Member Organizations from around the world contribute valuable perspectives, experiences, and expertise from across healthcare and science. In addition to collaborating on critical healthcare and science matters, every five years, Convention Members adopt USP Resolutions and elect USP’s Board of Trustees and the Council of Experts who lead USP’s standards-setting Expert Committees. Visit www.usp.org to learn more.

Website
http://www.usp.org
Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees
Headquarters
Rockville, Maryland
Type
Nonprofit
Founded
1820
Specialties
Product Quality–Standards and Verification, Healthcare Information, pharmaceuticals, Medicines quality, medicines safety, substandard medicines, falsified medicines, Medicines Supply Chain, COVID-19 Vaccines, Pharmaceuticals Advanced Manufacturing, and Pharmaceuticals Continuous Manufacturing

Locations

  • Primary

    12601 Twinbrook Parkway

    Rockville, Maryland 20852, US

    Get directions
  • USP-China

    United States Pharmacopeia R&D (Shanghai) Co., Ltd

    Shanghai, China 201203, US

    Get directions
  • USP Brazil

    Alameda Rio Negro, 500, Torre A, Sala 210 – Alphaville Industrial

    Barueri/SP, Brazil 06460-120, BR

    Get directions
  • USP–India Pvt. Ltd.

    ICICI Knowledge Park, Genome Valley Labs 7-10, Phase III

    Turkapally, Shamirpet Ranga Reddy District,, Hyderabad 500 078, IN

    Get directions
  • U.S. Pharmacopeia

    Munchensteinerstrasse 41

    Basel, Switzerland CH-4052, US

    Get directions
  • 520 North Fu Te Road

    China (Shanghai), Pilot Free Trade Zone

    Shanghai, China 200131, CN

    Get directions
  • 6th Floor, 335 Place,

    Plot No. 88, N1 Highway

    North-Dzorwulu, Accra,, GH

    Get directions
  • Biselex Building, 2nd Floor, Room 01

    Kebele 01/02 Along Bole Ring Road, P.O. Box 101232

    Addis Ababa, ET

    Get directions
  • House #34 Gausul Azam Avenue

    Sector # 13, Uttara

    Dhaka, 1230, BD

    Get directions
  • House No 405 Prasuti Griha Marga

    Ward No 11, Babarmahal

    Kathmandu, NP

    Get directions
  • 23 Ibrahim Tahir Lane

    Solutions Plaza, Cadastral Zone B05, Utako

    Abuja, NG

    Get directions
  • Jinnah Avenue, Islamabad Stock Exchange Tower, 55-B, Blue Area

    Office No. 308 & 309, 3rd Floor

    Islamabad, PK

    Get directions

Employees at US Pharmacopeia

Updates

  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    Reliance models are an essential component of achieving regulatory harmonization. Looking forward to next week's workshop where US Pharmacopeia's Kwasi Boateng will highlight progress toward regulatory reliance and the importance of complimentary regulatory capacity building at all levels. Thanks U.S. Trade and Development Agency (USTDA) and Corporate Council on Africa for organizing this workshop series on regulatory harmonization. Learn more: https://ow.ly/Eq1K50SyTq6

  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    Did you know that you can contribute to the standards development process? Share your comments on the proposed USP standards below by July 31, 2024. Proposed New Monographs: European Elder Berry Juice Concentrate, European Elder Berry Liquid Extract and Nicotinamide Riboside Chloride Proposed Monograph Revisions: Southern Schisandra Fruit and Southern Schisandra Fruit Powder Submit your feedback today: https://ow.ly/zUoM50RIfiX

    • No alternative text description for this image
  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    Webinar Announcement: New USP General Chapters <662> and <1662> We are excited to announce an upcoming webinar focused on the new USP General Chapters <662> and <1662>, which cover metal packaging materials and components. This insightful session will provide a comprehensive overview of the rationale behind these chapters, including their development history, purpose, and intent. We invite you to engage in a live Q&A discussion where key highlights will include: • Introduction of the new General Chapter <662> for Metal Packaging Systems, to be published in the Pharmacopeial Forum (PF) in July 2024. • In-depth discussion with USP Senior Principal Scientist Desmond G. Hunt and USP Expert Committee member Dr. Michael Eakins. • Q&A session to address your questions and provide further insights. We would like to encourage everyone to familiarize themselves with the chapter draft in the Pharmacopeial Forum (PF) before the webinar to make the most of the discussion. Register for this event below! ⬇

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    What two qualities are shared by all great US Pharmacopeia Expert Volunteers? USP Council of Experts Chair Jaap Venema who oversees all our volunteer efforts, has the answer. Hear more ⤵️ about what Jaap has to say about how passion for global #PublicHealth and an openness to debate make you an asset as a member of our global volunteer network. And, if you’re a pharmaceutical sciences expert working in industry, academia, science, healthcare, and beyond who stands out as a passionate collaborator, learn more how to apply as a #USPExpertVolunteer and amplify your impact: Bit.ly/USPExpertVolunteer #ProudToBeUSP #FridayFact

  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    #ICYMI: US Pharmacopeia convened key pharmaceutical associations, government, and healthcare stakeholders in Johannesburg for the inaugural meeting of our new Africa Regional Chapter. This event marked a significant milestone in USP’s decades-long commitment to Africa’s growing pharmaceutical sector. The launch of this Chapter establishes a crucial forum to advance the region’s priorities from strengthening local manufacturing and regulatory capabilities to combatting substandard medicines across the continent. Join us in celebrating this important step toward strengthening public health and patient safety across Africa and beyond. Visit Ow.ly/yAYo50ShYB9 to read more about the new chapter and our new #USPAccess4Africa initiative, also announced at the meeting. #USPConvention #GlobalHealth #Africa

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for US Pharmacopeia, graphic

    159,971 followers

    Did you know that the inactive ingredients in medicines are important to a drug’s safety and efficacy? Inactive ingredients, also known as excipients, can make up the majority of a medicine’s composition – up to 90 percent of a medicine’s total ingredients. Constituting such a significant portion of a medicine's total ingredients – and such important roles in a drug’s function – it’s no wonder that quality issues or shortages in excipients can lead to supply chain disruptions, drug shortages, and adverse patient outcomes. Read this article to learn more about USP's policy recommendations to help ensure medicine quality and supply chain resilience ⤵

    Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience 

    Excipients: A Blind Spot in Ensuring Medicine Quality and Supply Chain Resilience 

    US Pharmacopeia on LinkedIn

Affiliated pages

Similar pages

Browse jobs